CRYAB and central nervous system cancer: The studies of the Kore' group (2014[27]) revealed that CRYAB (HSPB5) was upregulated in the exosomes after inflammation response in glioma cells potentially induced the antiapoptotic response to applied treatment (Kore and Abraham, 2014[27]).